Latest Institute of Cancer Research Stories
In a study conducted by researchers at Moffitt Cancer Center and colleagues from 11 other institutions in the Unites States and the United Kingdom, genes that are known to be involved in inflammation were found to be related to risk of ovarian cancer.
An international research team led by the Research Institute of the McGill University Health Centre (RI MUHC) has made a major genetic breakthrough that could change the way pediatric cancers are treated in the future.
Patients with metastatic melanoma taking the recently approved drug vemurafenib (Zelboraf®) responded well to the twice daily pill, but some of them developed a different, secondary skin cancer.
A constellation of defective proteins suspected in causing a malfunction in the body’s ability to repair its own DNA could be the link scientists need to prove a new class of drugs will be effective in treating a broad range of ovarian cancer patients, an Oregon Health & Science University Knight Cancer Institute study found.
Vital Fundraising Initiative Fuels Research for Leading Cause of Cancer Deaths NEW YORK, July 20, 2011 /PRNewswire-USNewswire/ -- On August 14, more than 1,100 New Yorkers will put on their running shoes to fight a disease and honor the memories of the 1.3 million people each year who succumb to lung cancer.
About half of prostate cancers have a genetic anomaly that appears to make tumor cells responsive to a new class of cancer-fighting drugs.
The length of a man's index finger could help indicate how likely he is to develop prostate cancer, according to a new study published Wednesday in the British Journal of Cancer.
Researchers have shown that point mutations â€“ mis-spellings in a single letter of genetic code â€“ that drive the onset and growth of cancer cells can be detected successfully in advanced ovarian cancer using a technique called OncoMap.
NEW YORK, Oct. 26 /PRNewswire/ -- British scientists have identified a protein in urine that can help indicate which patients are at an increased risk of developing prostate cancer.